• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Leading Off: Prepare to re-evaluate your feline vaccination protocols

October 1, 2006
James R. Richards, DVM

More than a year in the making, the 2006 American Association of Feline Practitioners (AAFP) Feline Vaccine Advisory Panel Report is scheduled for publication in the Nov. 1 issue of the Journal of the American Veterinary Medical Association.

More than a year in the making, the 2006 American Association of Feline Practitioners (AAFP) Feline Vaccine Advisory Panel Report is scheduled for publication in the Nov. 1 issue of the Journal of the American Veterinary Medical Association. It will also be available on the AAFP (www.aafponline.org) and the American Veterinary Medical Association (www.avma.org) Web sites. The report comprises about 25,000 words, 15 sections, three tables, six appendices, and over 200 references. Despite its length, the document's arrangement allows for ready retrieval of information most important to practitioners, and the summary tables give quick access to key points. Plus, a more user-friendly encapsulation of the report will be available early next year.

EVIDENCE AND EXPERTISE

Hailing from universities and private practices in the United States, Canada, and the European Union, the 12 panelists cheerfully donated countless hours, sharing their experience and knowledge of feline infectious disease, internal medicine, immunology, epidemiology, shelter medicine, and clinical practice. The panel relied as much as possible on the growing number of applicable peer-reviewed studies. But when such studies were unavailable, the panel relied on the extensive experience of the panelists and the results of as-yet-unpublished studies. Needless to say, opinions differed on a few issues, such as at what age the kitten series should be concluded (12 weeks or 16 weeks?) and how often felv vaccines should be boosted in adult cats. But after careful consideration of all points of view and existing information, the panel unanimously supported the recommendations contained in the report. Both the aafp Guidelines Committee and the executive board approved the document in midsummer.

Advertisement

WHAT'S NEW?

So what can veterinarians expect? New are sections on vaccination in shelters, vaccination of cats in trap-neuter-return programs and of kittens in socialization classes, and vaccine administration. But much will be familiar. Vaccines are again classified as core, noncore, or not generally recommended. There are updated sections on the types of vaccines and routes of administration, immune responses to vaccination (including information on duration of immunity), laboratory tests to assess immunity, legal and regulatory considerations, and adverse events and reporting. Administering injectable vaccines in specific sites continues to be advised, with a re-emphasis on injection as distally as possible (sarcomas arising in the proximal limb are much more difficult to manage).

Of major interest is the section on the infectious diseases for which vaccines exist. Included are descriptions of each of the 10 agents, how they're transmitted and diagnosed, and which cats are most at risk of infection and disease. Also included are discussions of the types of vaccines available and what they're expected to accomplish, along with any recognized adverse events associated with vaccination. Panel recommendations for vaccine use are given for each infectious agent, with the most important material summarized in table form for easy access.

Changes are taking place rapidly in feline vaccinology. Vaccine manufacturers have quickly responded to many of the recommendations and concerns expressed in previous reports, including

  • Licensing of multivalent feline panleukopenia, feline herpesvirus, and feline calicivirus vaccines with demonstrated duration of immunity of at least three years

  • Funding of studies investigating the duration of vaccinal immunity in the real world, not just in the laboratory

  • Creation of appropriate monovalent products

  • Creation of multivalent formulations based on similar vaccine target populations (that is, cats with similar exposure and infection risk) and similar duration of immunity

  • Development of vaccines that create less inflammation at injectable vaccination sites

  • Production of vaccines with smaller doses

  • Development of novel methods of vaccine administration.

A LIVING DOCUMENT

Because of the changes taking place, the aafp Feline Vaccine Advisory Panel Report should be viewed as a living document subject to modification as new vaccines and new information come forth. The aafp remains committed to helping veterinarians provide the best care possible to their patients and clients and is proud to present this report to the profession.?

The members of the panel received no compensation for this work, nor were their efforts sponsored or funded by any manufacturer.

James R. Richards, DVM

James R. Richards, DVM, is director of the Cornell Feline Health Center, Cornell University College of Veterinary Medicine. He chaired the 2006 AAFP Feline Vaccine Advisory Panel and served on the 1998 and 2000 vaccine advisory panels.

Related Content:

Clinical
Newly funded study on chronic hepatitis in Doberman Pinschers
Newly funded study on chronic hepatitis in Doberman Pinschers
ABCs of dentistry: Airway, breathing, and circulation
ABCs of dentistry: Airway, breathing, and circulation
What's new with the "Dentistry Lane" across the veterinary profession?
What's new with the "Dentistry Lane" across the veterinary profession?

Advertisement

Latest News

Topical therapy and immunotherapy can save time and frustration with dermatology cases

Texas Tech appoints new faculty member with passion for animal agriculture

Valentine’s Day pet toxins

Newly funded study on chronic hepatitis in Doberman Pinschers

View More Latest News
Advertisement